Delivery Order SPE2DB20D2001-SPE2DB24FM48L
Award Date 3/6/24
Potential Completion Date 3/7/24
Potential Value $16K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The order has a potential value of $6,281.36 and a completion date of February 2, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the drug Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has a ceiling value of $2,569.57 and a performance period through April 11, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has a potential value of $2,177.10 and a period of performance through March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) it holds with DLA valued at up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pen 0.5 ml pharmaceuticals. The $6,720.96 award has an ultimate completion date of April 4, 2024 and is not associated with any set-aside designation. AmerisourceBergen Drug Corp is the prime contractor on this delivery order and also holds an indefinite delivery contract (IDC) with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The $3,612.14 contract has an ultimate completion date of April 5, 2024 and does not utilize any set-aside designations. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pens. The $2,437.92 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary contract vehicle for the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $1,500.43, to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Trulicity 0.75 mg/0.5 ml pen 0.5 ml medication. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) valued at up to $999,999,999.00, which serves as the primary vehicle for AmerisourceBergen to deliver pharmaceutical products and medical supplies to DLA...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Trulicity 0.75 mg/0.5 ml pens. The contract has a completion date of January 31, 2024 and a potential value of $3,860.10. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4,564,198,730 units of the medication Trulicity 1.5 mg/0.5 ml pen. The contract, valued at $3,047.94, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp, as the prime contractor, will provide these pharmaceutical products to DLA Troop Support Medical facilities in support of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Trulicity 1.5 mg/0.5 ml pens. The order, valued at $2,902.80, has a completion date of March 4, 2024. Amerisourcebergen Drug Corp is a prime contractor that holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB24FM48LDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the medication Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has a potential value of $15,516.30 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was not set aside for any particular business type.
Generated 6/5/24, 10:28 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.5k | 3/6/24 |